Sumeer Thinda is an Ophthalmology physician affiliated with The California Eye Institute. OpenAlex indexes 31 publications with 232 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
95.4%Antineovascularisation agents92.7%Faricimab-svoa100%Part B, office-administered≥90 patientsVascular Endothelial Growth Factor Inhibitor1.5%Ranibizumab100%Part B, office-administered≥35 patients+ 7 more classes in this area
Cancer & immunology
4.4%Vascular Endothelial Growth Factor Inhibitor4.3%Aflibercept100%Part B, office-administered≥179 patientsCalcineurin inhibitor0.1%Restasis64%Cyclosporine36%Part D<11 patientsMusculoskeletal
0.1%Cyclooxygenase Inhibitor0.1%Ketorolac Tromethamine100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Structural and refractive outcomes of intravitreal ranibizumab followed by laser photocoagulation for type 1 retinopathy of prematurity
Journal of American Association for Pediatric Ophthalmology and Strabismus
2022 - Outcomes of intravitreal ranibizumab followed by laser photocoagulation for type 1 retinopathy of prematurity
Journal of American Association for Pediatric Ophthalmology and Strabismus
2022 - Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema
European Journal of Ophthalmology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”